PNT - POINT Biopharma Global Inc
IEX Last Trade
8.5
-0.060 -0.706%
Share volume: 673,572
Last Updated: Tue 08 Aug 2023 09:59:51 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$8.56
-0.06
-0.70%
Fundamental analysis
26%
Profitability
35%
Dept financing
3%
Liquidity
75%
Performance
10%
Performance
5 Days
-4.25%
1 Month
-7.36%
3 Months
7.27%
6 Months
7.40%
1 Year
4.90%
2 Year
-8.06%
Key data
Stock price
$8.50
DAY RANGE
N/A - N/A
52 WEEK RANGE
$5.59 - $11.13
52 WEEK CHANGE
-$0.01
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Joe A. McCann
Region: US
Website: pointbiopharma.com
Employees: 132
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: pointbiopharma.com
Employees: 132
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
a novel, research based biotechnology company focused on the development and commercialization of radiopharmaceutical products to meet unmet patient needs
Recent news